NADEEM PAROYA: Open Payments
NPI 1790765303 · THORNDALE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,509 in 80 payments from 18 companies in 2025. Trend: 2023 $1,362 · 2024 $1,049 · 2025 $1,509
Food & beverage: $1,502Education: $7
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 11 | $215 |
| AstraZeneca Pharmaceuticals LP | 11 | $213 |
| Novo Nordisk Inc | 11 | $180 |
| GlaxoSmithKline, LLC. | 9 | $157 |
| Lundbeck LLC | 6 | $140 |
| ABBVIE INC. | 6 | $105 |
| Mannkind Corporation | 4 | $103 |
| Intra-Sana Laboratories | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $56 |
| Exact Sciences Corporation | 3 | $55 |
Products named: REXULTI, JARDIANCE, MOUNJARO, TRELEGY ELLIPTA, BREZTRI, AFREZZA, Rybelsus, VRAYLAR.
Industry payments across PA — which companies pay providers there.
